Genomic Valley Biotech Live Share Price Today, Share Analysis and Chart

Name: Genomic Valley Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Genomic Valley Biotech Ltd.
Rating: 1.50691675
Author: Trendlyne DVM scores

Iran war impact

Based on the latest available financial reports and management disclosures for Genomic Valley Biotech Ltd. (GVBL) as of March 2026, the impact of the ongoing conflict in the Middle East is outlined below. ### Impact Overview: Minimal to Neutral T...

28.80 1.35 (4.92%)

55.00% Fall from 52W High

1,924

BSE Volume

BSE 13 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Expensive Valuation

- / 100

Technically Neutral

50.6 / 100

No estimates available

Genomic Valley Biotech Live Price Chart

Loading Fundamental data..

Loading data..

Is Genomic Valley Biotech Ltd. worth buying?

6 Votes:

Buy 33.33%

Sell 50.0%

Hold 16.67%

Genomic Valley Biotech Live Share Price Today, Share Analysis and Chart

Based on the latest available financial reports and management disclosures for Genomic Valley Biotech Ltd. (GVBL) as of March 2026, the impact of the ongoing conflict in the Middle East is outlined below. ### Impact Overview: Minimal to Neutral T...

55.00% Fall from 52W High

SWOT Analysis

Genomic Valley Biotech Live Price Chart